Patient-reported outcome (PRO)-based symptom assessment in patients with advanced lung cancer receiving first-line combination immunotherapy: a protocol for a multicenter, prospective, observational study

BACKGROUND: Immunotherapy is currently applied in the first-line treatment regimens for numerous advanced cancers, especially advanced lung cancer. Immune-related adverse events (irAEs) resulting from immunotherapy can vary in severity and cause a substantial symptom burden to patients. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Yuanle, Hu, Han, Jia, Rong, Dai, Wei, Wang, Dengfeng, Zhang, Purong, Zhang, Peng, Cheng, Kai, Tang, Jianning, Wen, Yan, Zhou, Xiang, Shi, Qiuling, Xiong, Zhujuan, Zhou, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199466/
https://www.ncbi.nlm.nih.gov/pubmed/37208661
http://dx.doi.org/10.1186/s12890-023-02432-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199466/
https://www.ncbi.nlm.nih.gov/pubmed/37208661
http://dx.doi.org/10.1186/s12890-023-02432-5

Ejemplares similares